• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $OXFD

    Oxford Immunotec Global PLC

    Subscribe to $OXFD
    $OXFD
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    IPO Year: 2013

    Exchange: NASDAQ

    Recent Analyst Ratings for Oxford Immunotec Global PLC

    DatePrice TargetRatingAnalyst
    See more ratings

    Oxford Immunotec Global PLC SEC Filings

    See more
    • SEC Form 15-12B filed by Oxford Immunotec Global PLC

      15-12B - Oxford Immunotec Global PLC (0001586049) (Filer)

      3/18/21 4:35:17 PM ET
      $OXFD
      Biotechnology: In Vitro & In Vivo Diagnostic Substances
      Health Care
    • SEC Form S-8 POS filed

      S-8 POS - Oxford Immunotec Global PLC (0001586049) (Filer)

      3/12/21 4:38:00 PM ET
      $OXFD
      Biotechnology: In Vitro & In Vivo Diagnostic Substances
      Health Care
    • SEC Form S-8 POS filed

      S-8 POS - Oxford Immunotec Global PLC (0001586049) (Filer)

      3/12/21 4:35:16 PM ET
      $OXFD
      Biotechnology: In Vitro & In Vivo Diagnostic Substances
      Health Care
    • SEC Form 8-K filed

      8-K - Oxford Immunotec Global PLC (0001586049) (Filer)

      3/8/21 4:35:32 PM ET
      $OXFD
      Biotechnology: In Vitro & In Vivo Diagnostic Substances
      Health Care
    • SEC Form 25-NSE filed

      25-NSE - Oxford Immunotec Global PLC (0001586049) (Subject)

      3/8/21 9:24:11 AM ET
      $OXFD
      Biotechnology: In Vitro & In Vivo Diagnostic Substances
      Health Care
    • SEC Form 8-K/A filed

      8-K/A - Oxford Immunotec Global PLC (0001586049) (Filer)

      3/2/21 5:00:13 PM ET
      $OXFD
      Biotechnology: In Vitro & In Vivo Diagnostic Substances
      Health Care
    • SEC Form 8-K filed

      8-K - Oxford Immunotec Global PLC (0001586049) (Filer)

      2/26/21 5:17:14 PM ET
      $OXFD
      Biotechnology: In Vitro & In Vivo Diagnostic Substances
      Health Care
    • SEC Form SC 13D filed

      SC 13D - Oxford Immunotec Global PLC (0001586049) (Subject)

      1/29/21 9:54:56 AM ET
      $OXFD
      Biotechnology: In Vitro & In Vivo Diagnostic Substances
      Health Care
    • SEC Form DEFM14A filed

      DEFM14A - Oxford Immunotec Global PLC (0001586049) (Filer)

      1/29/21 9:27:31 AM ET
      $OXFD
      Biotechnology: In Vitro & In Vivo Diagnostic Substances
      Health Care
    • SEC Form PREM14A filed

      PREM14A - Oxford Immunotec Global PLC (0001586049) (Filer)

      1/19/21 5:23:03 PM ET
      $OXFD
      Biotechnology: In Vitro & In Vivo Diagnostic Substances
      Health Care

    Oxford Immunotec Global PLC Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4: Herm Rosenman disposed to the issuer $89,782 worth of Ordinary Shares (4,081 units at $22.00), decreasing direct ownership by 100% to 0 units

      4 - Oxford Immunotec Global PLC (0001586049) (Issuer)

      3/12/21 4:37:45 PM ET
      $OXFD
      Biotechnology: In Vitro & In Vivo Diagnostic Substances
      Health Care
    • SEC Form 4: E T Matthew Mclaughlin disposed to the issuer $1,350,954 worth of Ordinary Shares (61,407 units at $22.00), decreasing direct ownership by 100% to 0 units

      4 - Oxford Immunotec Global PLC (0001586049) (Issuer)

      3/12/21 4:37:19 PM ET
      $OXFD
      Biotechnology: In Vitro & In Vivo Diagnostic Substances
      Health Care
    • SEC Form 4: A Richard Sandberg disposed to the issuer $89,782 worth of Ordinary Shares (4,081 units at $22.00), decreasing direct ownership by 100% to 0 units

      4 - Oxford Immunotec Global PLC (0001586049) (Issuer)

      3/12/21 4:36:57 PM ET
      $OXFD
      Biotechnology: In Vitro & In Vivo Diagnostic Substances
      Health Care
    • SEC Form 4: R. Mark Klausner disposed to the issuer $89,782 worth of Ordinary Shares (4,081 units at $22.00), decreasing direct ownership by 100% to 0 units

      4 - Oxford Immunotec Global PLC (0001586049) (Issuer)

      3/12/21 4:36:45 PM ET
      $OXFD
      Biotechnology: In Vitro & In Vivo Diagnostic Substances
      Health Care
    • SEC Form 4: Patricia Randall disposed to the issuer $611,710 worth of Ordinary Shares (27,805 units at $22.00), decreasing direct ownership by 100% to 0 units

      4 - Oxford Immunotec Global PLC (0001586049) (Issuer)

      3/12/21 4:36:14 PM ET
      $OXFD
      Biotechnology: In Vitro & In Vivo Diagnostic Substances
      Health Care
    • SEC Form 4: Louise Janet Kidd disposed to the issuer $246,554 worth of Ordinary Shares (11,207 units at $22.00), decreasing direct ownership by 100% to 0 units

      4 - Oxford Immunotec Global PLC (0001586049) (Issuer)

      3/12/21 4:36:16 PM ET
      $OXFD
      Biotechnology: In Vitro & In Vivo Diagnostic Substances
      Health Care
    • SEC Form 4: J Patrick Balthrop disposed to the issuer $177,782 worth of Ordinary Shares (8,081 units at $22.00), decreasing direct ownership by 100% to 0 units

      4 - Oxford Immunotec Global PLC (0001586049) (Issuer)

      3/12/21 4:36:01 PM ET
      $OXFD
      Biotechnology: In Vitro & In Vivo Diagnostic Substances
      Health Care
    • SEC Form 4: Scott Andrew Walton disposed to the issuer $89,782 worth of Ordinary Shares (4,081 units at $22.00), decreasing direct ownership by 100% to 0 units

      4 - Oxford Immunotec Global PLC (0001586049) (Issuer)

      3/12/21 4:35:55 PM ET
      $OXFD
      Biotechnology: In Vitro & In Vivo Diagnostic Substances
      Health Care
    • SEC Form 4: Peter Wrighton-Smith disposed to the issuer $8,804,950 worth of Ordinary Shares (400,225 units at $22.00), decreasing direct ownership by 100% to 0 units

      4 - Oxford Immunotec Global PLC (0001586049) (Issuer)

      3/12/21 4:35:55 PM ET
      $OXFD
      Biotechnology: In Vitro & In Vivo Diagnostic Substances
      Health Care
    • SEC Form 4: Asbury Ronald Andrews disposed to the issuer $89,782 worth of Ordinary Shares (4,081 units at $22.00), decreasing direct ownership by 100% to 0 units

      4 - Oxford Immunotec Global PLC (0001586049) (Issuer)

      3/12/21 4:35:37 PM ET
      $OXFD
      Biotechnology: In Vitro & In Vivo Diagnostic Substances
      Health Care